
- This event has passed.
1st Oncobell symposium – Mechanisms of Cancer and New Therapeutic Strategies
20 September, 2018 @ 9:00 am - 21 September, 2018 @ 5:30 pm



About ONCOBELL
Oncobell is a joint research program focused on molecular mechanisms and experimental therapies in cancer. It is a new program within the IDIBELL with the aim to fight cancer in a collective and multidisciplinary way. It includes an array of groups that cover the stages from basic frontier research all the way to clinical treatments of the patients.
The common nominator of the program is that all groups work on improving patients’ outcomes through either a molecular/pathway oriented approach or through a disease and clinical needs oriented approach. We believe that increasing the communication between groups linking these two approaches will lead to better ideas and shortcuts in the transition between lab results into the clinics.
Contact: oncobellsymposium@idibell.cat
The new work developed in the lab of META-CAN’s coordinator, Cristina Muñoz-Pinedo, has finally seen the light in a paper at PNAS. The study has been possible thanks to an amazing group of researchers and the funding of two MSCA Actions: TRAINERS (GA 675448) and META-CAN (GA 766214).
MetaboList - June 2020
A lot to read this summer :)
#Metabolism #Diet #Cancer https://metabolist.wordpress.com/2020/07/01/metabolist-june-2020/
ApoList - June 2020
Reads for the Summer
#Apoptosis #CellDeath #BCL2 https://celldeath.wordpress.com/2020/07/01/apolist-june-2020/

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain